Non-Small Cell Lung Cancer, Version 5.2017 Clinical Practice Guidelines in Oncology

被引：966

作者：

Ettinger, David S. ^{[1
]}

Wood, Douglas E. ^{[2
]}

Aisner, Dara L. ^{[3
]}

Akerley, Wallace ^{[4
]}

Bauman, Jessica ^{[5
]}

Chirieac, Lucian R. ^{[6
]}

D'Amico, Thomas A. ^{[7
]}

DeCamp, Malcolm M. ^{[8
]}

Dilling, Thomas J. ^{[9
]}

Dobelbower, Michael ^{[10
]}

Doebele, Robert C. ^{[11
]}

Govindan, Ramaswamy ^{[12
,13
]}

Gubens, Matthew A. ^{[14
]}

Hennon, Mark ^{[15
]}

Horn, Leora ^{[16
]}

Komaki, Ritsuko ^{[17
]}

Lackner, Rudy P. ^{[18
]}

Lanuti, Michael ^{[19
]}

Leal, Ticiana A. ^{[20
]}

Leisch, Leah J. ^{[10
]}

Lilenbaum, Rogerio ^{[21
]}

Lin, Jules ^{[22
]}

Loo, Billy W., Jr. ^{[23
]}

Martins, Renato ^{[24
]}

Otterson, Gregory A. ^{[25
,26
]}

Reckamp, Karen ^{[27
]}

Riely, Gregory J. ^{[28
]}

Schild, Steven E. ^{[29
]}

Shapiro, Theresa A. ^{[30
]}

Stevenson, James ^{[31
,32
]}

Swanson, Scott J. ^{[6
]}

Tauer, Kurt ^{[33
]}

Yang, Stephen C. ^{[30
]}

Gregory, Kristina

Hughes, Miranda

机构：

[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Med Oncol, Baltimore, MD USA

[2] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Surg Surg Oncol, Seattle, WA USA

[3] Univ Colorado, Canc Ctr, Pathol, Boulder, CO 80309 USA

[4] Univ Utah, Huntsman Canc Inst, Med Oncol, Salt Lake City, UT 84112 USA

[5] Fox Chase Canc Ctr, Hematol Hematol Oncol, Philadelphia, PA USA

[6] Dana Farber Brigham & Womens Canc Ctr, Surg Surg Oncol, Pathol, Boston, MA USA

[7] Duke Canc Inst, Surg Surg Oncol, Durham, NC USA

[8] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Surg Surg Oncol, Evanston, IL 60208 USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Radiat Oncol Radiotherapy, Tampa, FL USA

[10] Univ Alabama, Birmingham Comprehens Canc Ctr, Internal Med, Tuscaloosa, AL 35487 USA

[11] Univ Colorado, Canc Ctr, Med Oncol, Boulder, CO 80309 USA

[12] Barnes Jewish Hosp, Siteman Canc Ctr, Med Oncol, St Louis, MO USA

[13] Washington Univ, Sch Med, Med Oncol, St Louis, MO 63130 USA

[14] UCSF, Helen Diller Family Comprehens Canc Ctr, Med Oncol, San Francisco, CA USA

[15] Roswell Pk Canc Inst, Surg Surg Oncol, Buffalo, NY USA

[16] Vanderbilt Ingram Canc Ctr, Med Oncol, Nashville, TN USA

[17] Univ Texas MD Anderson Canc Ctr, Radiat Oncol Radiotherapy, Houston, TX USA

[18] Fred & Pamela Buffett Canc Ctr, Surg Surg Oncol, Omaha, NE USA

[19] Massachusetts Gen Hosp, Canc Ctr, Surg Surg Oncol, Boston, MA 02114 USA

[20] Univ Wisconsin, Carbone Canc Ctr, Med Oncol, Madison, WI 53706 USA

[21] Smilow Canc Hosp, Yale Canc Ctr, Med Oncol, New Haven, CT USA

[22] Univ Michigan, Comprehens Canc Ctr, Surg Surg Oncol, Ann Arbor, MI 48109 USA

[23] Stanford Canc Inst, Radiat Oncol Radiotherapy, Stanford, CA USA

[24] Seattle Canc Care Alliance, Fred Hutchinson Canc Res Ctr, Med Oncol, Seattle, WA USA

[25] Ohio State Univ, Comprehens Canc Ctr, James Canc Hosp, Med Oncol,Internal Med, Columbus, OH 43210 USA

[26] Solove Res Inst, Med Oncol, Columbus, OH USA

[27] City Hope Comprehens Canc Ctr, Med Oncol, Pathol, Hematol Hematol Oncol, Duarte, CA USA

[28] Mem Sloan Kettering Canc Ctr, New York, NY USA

[29] Mayo Clin, Canc Ctr, Radiat Oncol Radiotherapy, Rochester, MN USA

[30] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Surg Surg Oncol, Baltimore, MD USA

[31] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Med Oncol, Cleveland, OH USA

[32] Cleveland Clin Taussig Canc Inst, Med Oncol, Cleveland, OH USA

[33] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Med Oncol, Knoxville, TN 37996 USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2017年 / 15卷 / 04期

关键词：

GROWTH-FACTOR-RECEPTOR; ANAPLASTIC LYMPHOMA KINASE; RANDOMIZED PHASE-III; IMMUNE-RELATED RESPONSE; QUALITY-OF-LIFE; PLATINUM-BASED CHEMOTHERAPY; ESMO CONSENSUS CONFERENCE; RAS ONCOGENE ACTIVATION; ALK GENE REARRANGEMENT; BODY RADIATION-THERAPY;

D O I：

10.6004/jnccn.2017.0050

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezoli-zumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

引用

页码：504 / 535

页数：32

共 252 条

[1]

WHO, RECIST, and immune-related response criteria: is it time to revisit pembrolizumab results? [J].

Ades, Felipe ;

Yamaguchi, Nise .

ECANCERMEDICALSCIENCE, 2015, 9

[2]

ALK Rearrangement in a Large Series of Consecutive Non-Small Cell Lung Cancers [J].

Ali, Greta ;

Proietti, Agnese ;

Pelliccioni, Serena ;

Niccoli, Cristina ;

Lupi, Cristiana ;

Sensi, Elisa ;

Giannini, Riccardo ;

Borrelli, Nicla ;

Menghi, Maura ;

Chella, Antonio ;

Ribechini, Alessandro ;

Cappuzzo, Federico ;

Melfi, Franca ;

Lucchi, Marco ;

Mussi, Alfredo ;

Fontanini, Gabriella .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (11) :1449-1458

[3]

Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization [J].

Ali, Siraj M. ;

Hensing, Thomas ;

Schrock, Alexa B. ;

Allen, Justin ;

Sanford, Eric ;

Gowen, Kyle ;

Kulkarni, Atul ;

He, Jie ;

Suh, James H. ;

Lipson, Doron ;

Elvin, Julia A. ;

Yelensky, Roman ;

Chalmers, Zachary ;

Chmielecki, Juliann ;

Peled, Nir ;

Klempner, Samuel J. ;

Firozvi, Kashif ;

Frampton, Garrett M. ;

Molina, Julian R. ;

Menon, Smitha ;

Brahmer, Julie R. ;

MacMahon, Heber ;

Nowak, Jan ;

Ou, Sai-Hong Ignatius ;

Zauderer, Marjorie ;

Ladanyi, Marc ;

Zakowski, Maureen ;

Fischbach, Neil ;

Ross, Jeffrey S. ;

Stephens, Phil J. ;

Miller, Vincent A. ;

Wakelee, Heather ;

Ganesan, Shridar ;

Salgia, Ravi .

ONCOLOGIST, 2016, 21 (06) :762-770

[4]

Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer - a randomized trial with quality of life as the primary outcome [J].

Anderson, H. ;

Hopwood, P. ;

Stephens, R. J. ;

Thatcher, N. ;

Cottier, B. ;

Nicholson, M. ;

Milroy, R. ;

Maughan, T. S. ;

Falk, S. J. ;

Bond, M. G. ;

Burt, P. A. ;

Connolly, C. K. ;

McIllmurray, M. B. ;

Carmichael, J. .

BRITISH JOURNAL OF CANCER, 2000, 83 (04) :447-453

[5]

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer (vol 368, pg 2385, 2013) [J].

不详 .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (16) :1582-1582

[6]

[Anonymous], 2013, ONCOLOGY-NY, V27, P813

[7]

[Anonymous], 16 WORLD C LUNG CANC

[8]

[Anonymous], 16 WORLD C LUNG CANC

[9]

[Anonymous], J CLIN ONCOL S18

[10]

[Anonymous], 2013, AM SOC CLIN ONCOL ED

← 1 2 3 4 5 6 7 8 9 10 →